Shiro Koizume

1.3k total citations
37 papers, 1.0k citations indexed

About

Shiro Koizume is a scholar working on Molecular Biology, Hematology and Cancer Research. According to data from OpenAlex, Shiro Koizume has authored 37 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 12 papers in Hematology and 12 papers in Cancer Research. Recurrent topics in Shiro Koizume's work include Blood Coagulation and Thrombosis Mechanisms (11 papers), Cancer, Hypoxia, and Metabolism (8 papers) and RNA modifications and cancer (8 papers). Shiro Koizume is often cited by papers focused on Blood Coagulation and Thrombosis Mechanisms (11 papers), Cancer, Hypoxia, and Metabolism (8 papers) and RNA modifications and cancer (8 papers). Shiro Koizume collaborates with scholars based in Japan, United States and United Kingdom. Shiro Koizume's co-authors include Yohei Miyagi, Yoshiyasu Nakamura, Yuji Sakuma, Etsuko Miyagi, Mitsuyo Yoshihara, Fumiki Hirahara, Wolfram Ruf, Akira Yoshida, Eiju Tsuchiya and Shoichi Matsukuma and has published in prestigious journals such as Nucleic Acids Research, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Shiro Koizume

36 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shiro Koizume Japan 18 487 239 224 170 135 37 1.0k
David Cervi United States 13 554 1.1× 226 0.9× 281 1.3× 377 2.2× 57 0.4× 21 948
Sarah Beck Germany 16 534 1.1× 89 0.4× 258 1.2× 203 1.2× 67 0.5× 30 1.0k
Hans Kristian Moen Vollan Norway 18 705 1.4× 573 2.4× 41 0.2× 466 2.7× 31 0.2× 25 1.3k
Sonia Caccia Italy 21 351 0.7× 116 0.5× 518 2.3× 81 0.5× 20 0.1× 38 1.3k
Omar Moussa United States 19 423 0.9× 203 0.8× 61 0.3× 140 0.8× 6 0.0× 25 828
Tone Sandal Norway 13 488 1.0× 145 0.6× 26 0.1× 430 2.5× 17 0.1× 16 1.1k
P. O’Grady United States 13 587 1.2× 434 1.8× 167 0.7× 274 1.6× 6 0.0× 19 1.1k
Vernon T. Phan United States 12 583 1.2× 164 0.7× 202 0.9× 252 1.5× 5 0.0× 16 875
Nathan G. Dolloff United States 19 877 1.8× 296 1.2× 245 1.1× 515 3.0× 5 0.0× 41 1.4k
Adam Shutes United States 16 847 1.7× 104 0.4× 92 0.4× 186 1.1× 5 0.0× 19 1.2k

Countries citing papers authored by Shiro Koizume

Since Specialization
Citations

This map shows the geographic impact of Shiro Koizume's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shiro Koizume with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shiro Koizume more than expected).

Fields of papers citing papers by Shiro Koizume

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shiro Koizume. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shiro Koizume. The network helps show where Shiro Koizume may publish in the future.

Co-authorship network of co-authors of Shiro Koizume

This figure shows the co-authorship network connecting the top 25 collaborators of Shiro Koizume. A scholar is included among the top collaborators of Shiro Koizume based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shiro Koizume. Shiro Koizume is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Koizume, Shiro, et al.. (2026). Tissue Factor as a Prognostic and Therapeutic Biomarker in Resected Pancreatic Cancer. Annals of Surgical Oncology.
2.
Koizume, Shiro & Yohei Miyagi. (2025). Adaptation mechanisms in cancer: Lipid metabolism under hypoxia and nutrient deprivation as a target for novel therapeutic strategies (Review). Molecular Medicine Reports. 31(4). 2 indexed citations
3.
Ota, Yukihide, Yukio Suzuki, Shiro Koizume, et al.. (2024). Tissue factor pathway inhibitor 2 as a serum biomarker for endometrial cancer: a single-center retrospective study. BMC Cancer. 24(1). 1058–1058. 2 indexed citations
4.
Kasajima, Rika, Koichi Azuma, Tomoyuki Tagami, et al.. (2024). Multi-omics analysis-based clinical and functional significance of a novel prognostic and immunotherapeutic gene signature derived from amino acid metabolism pathways in lung adenocarcinoma. Frontiers in Immunology. 15. 1361992–1361992. 3 indexed citations
5.
Koizume, Shiro, Tomoko Takahashi, Yoshiyasu Nakamura, et al.. (2022). Lipophagy-ICAM-1 pathway associated with fatty acid and oxygen deficiencies is involved in poor prognoses of ovarian clear cell carcinoma. British Journal of Cancer. 127(3). 462–473. 4 indexed citations
6.
Koizume, Shiro & Yohei Miyagi. (2017). Potential Coagulation Factor-Driven Pro-Inflammatory Responses in Ovarian Cancer Tissues Associated with Insufficient O2 and Plasma Supply. International Journal of Molecular Sciences. 18(4). 809–809. 10 indexed citations
7.
Koizume, Shiro & Yohei Miyagi. (2016). Lipid Droplets: A Key Cellular Organelle Associated with Cancer Cell Survival under Normoxia and Hypoxia. International Journal of Molecular Sciences. 17(9). 1430–1430. 164 indexed citations
8.
Koizume, Shiro & Yohei Miyagi. (2015). Anti-apoptotic genes are synergistically activated in OVSAYO cells cultured under conditions of serum starvation and hypoxia. Genomics Data. 5. 129–131. 4 indexed citations
9.
Omata, Taku, Jun‐ichi Nagai, Hiroko Shimbo, et al.. (2015). A splicing mutation of proteolipid protein 1 in Pelizaeus-Merzbacher disease. Brain and Development. 38(6). 581–584. 3 indexed citations
10.
Koizume, Shiro, Shin Ito, Yoshiyasu Nakamura, et al.. (2015). Lipid starvation and hypoxia synergistically activate ICAM1 and multiple genes in an Sp1-dependent manner to promote the growth of ovarian cancer. Molecular Cancer. 14(1). 77–77. 28 indexed citations
11.
Yokota, Naho, Mikiko Asai‐Sato, Roppei Yamada, et al.. (2013). Annexin A4 Is Involved in Proliferation, Chemo-Resistance and Migration and Invasion in Ovarian Clear Cell Adenocarcinoma Cells. PLoS ONE. 8(11). e80359–e80359. 40 indexed citations
12.
Sakuma, Yuji, Shoichi Matsukuma, Yoshiyasu Nakamura, et al.. (2013). Enhanced autophagy is required for survival in EGFR-independent EGFR-mutant lung adenocarcinoma cells. Laboratory Investigation. 93(10). 1137–1146. 43 indexed citations
13.
Koizume, Shiro, Shin Ito, Etsuko Miyagi, et al.. (2012). HIF2α-Sp1 interaction mediates a deacetylation-dependent FVII- gene activation under hypoxic conditions in ovarian cancer cells. Nucleic Acids Research. 40(12). 5389–5401. 40 indexed citations
14.
Yoshida, Akira, Hiroyuki Hayashi, Mitsuyo Yoshihara, et al.. (2012). The Associations Between RAS Mutations and Clinical Characteristics in Follicular Thyroid Tumors: New Insights from a Single Center and a Large Patient Cohort. Thyroid. 22(7). 683–689. 110 indexed citations
15.
Sakuma, Yuji, Yukiko Yamazaki, Yoshiyasu Nakamura, et al.. (2011). WZ4002, a third-generation EGFR inhibitor, can overcome anoikis resistance in EGFR-mutant lung adenocarcinomas more efficiently than Src inhibitors. Laboratory Investigation. 92(3). 371–383. 42 indexed citations
16.
Koizume, Shiro, Naho Yokota, Etsuko Miyagi, et al.. (2009). Hepatocyte Nuclear Factor-4–Independent Synthesis of Coagulation Factor VII in Breast Cancer Cells and Its Inhibition by Targeting Selective Histone Acetyltransferases. Molecular Cancer Research. 7(12). 1928–1936. 38 indexed citations
17.
Yokota, Naho, Shiro Koizume, Etsuko Miyagi, et al.. (2009). Self-production of tissue factor-coagulation factor VII complex by ovarian cancer cells. British Journal of Cancer. 101(12). 2023–2029. 66 indexed citations
18.
Koizume, Shiro, Naho Yokota, Etsuko Miyagi, et al.. (2008). Heterogeneity in binding and gene-expression regulation by HIF-2α. Biochemical and Biophysical Research Communications. 371(2). 251–255. 6 indexed citations
19.
Koizume, Shiro, Shuichi Takizawa, Kazutoshi Fujita, et al.. (2006). Aberrant trafficking of a proteolipid protein in a mild Pelizaeus-Merzbacher disease. Neuroscience. 141(4). 1861–1869. 10 indexed citations
20.
Koizume, Shiro, Ken Tachibana, & Masahiko Shiraishi. (2003). Treatment of Tumor Cells with Histone Deacetylase Inhibitors Results in Altered Recruitment of Methyl-CpG Binding Proteins to a Methylated CpG Island. Biological Chemistry. 384(5). 787–90. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by David Cervi Breakdown of academic impact, for papers by Sarah Beck Breakdown of academic impact, for papers by Hans Kristian Moen Vollan Breakdown of academic impact, for papers by Sonia Caccia Breakdown of academic impact, for papers by Omar Moussa Breakdown of academic impact, for papers by Tone Sandal Breakdown of academic impact, for papers by P. O’Grady Breakdown of academic impact, for papers by Vernon T. Phan Breakdown of academic impact, for papers by Nathan G. Dolloff Breakdown of academic impact, for papers by Adam Shutes
Rankless by CCL
2026